Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway

Neuroscience Letters

Volumn 444, Issue 1, 2008, Pages 74-78

  Koh, Phil Ok ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

Melatonin; mTOR; Neuroprotection; p70S6 kinase

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MELATONIN; PROTEIN KINASE B; S6 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CELL LINE, TRANSFORMED; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; GLUTAMATES; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MELATONIN; MICE; NEURONS; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 50849106068     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.08.024     Document Type: Article

References (29)

1. Cuzzocrea S., Costantino G., Gitto E., Mazzon E., Fulia F., Serraino I., Cordaro S., Barberi I., De Sarro A., and Caputi A.P. Protective effects of melatonin in ischemic brain injury. J. Pineal Res. 29 (2000) 217-227
2. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
3. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13 (1999) 2905-2927
4. Dufner A., and Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253 (1999) 100-109
5. Feng Z., and Zhang J.T. Protective effect of melatonin on beta-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic. Biol. Med. 73 (2004) 1790-1801
6. Gingras A.C., Raught B., and Sonenberg N. Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27 (2001) 143-174
7. Harada H., Andersen J.S., Mann M., Terada N., and Korsmeyer S.J. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9666-9670
8. Herrera F., Martin V., Garcia-Santos G., Rodriguez-Blanco G.J., Antolin I., and Rodriguez C. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria. J. Neurochem. 100 (2007) 736-746
9. Janelidze S., Hu B.R., Siesjo P., and Siesjo B.K. Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia. Neurobiol. Dis. 8 (2001) 147-154
10. Kilic U., Kilic E., Reiter R.J., Bassetti C.L., and Hermann D.M. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J. Pineal Res. 38 (2005) 67-71
11. Kis A., Yellon D.M., and Baxter G.F. Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J. Mol. Cell Cardiol. 35 (2003) 1063-1071
12. Koh P.O. Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J. Pineal Res. 44 (2008) 101-106
13. Koh P.O. Melatonin prevents the injury-induced decline of Akt/forkhead transcription factors phosphorylation. J. Pineal Res. 45 (2008) 199-203
14. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M.C., Gil R., Pradier L., and Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J. Neurochem. 94 (2005) 215-225
15. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
16. Maher P., and Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16 (1996) 6394-6401
17. Maldonado M.D., Murillo-Cabezas F., Terron M.P., Flores L.J., Tan D.X., Manchester L.C., and Reiter R.J. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J. Pineal Res. 42 (2007) 1-11
18. Manda K., Ueno M., and Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J. Pineal Res. 42 (2007) 386-393
19. Mengesdorf T., Proud C.G., Miles G., and Paschen W. Mechanisms underlying suppression of protein synthesis induced by transient focal cerebral ischemia in mouse brain. Exp. Neurol. 177 (2002) 538-546
20. Nomura M., Shimizu S., Sugiyama T., Narita M., Ito T., Matsuda H., and Tsujimoto Y. 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J. Biol. Chem. 278 (2002) 2058-2065
21. Pei Z., Pang S.F., and Cheung R.T. Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J. Pineal Res. 32 (2002) 168-172
22. Pei Z., Fung P.C., and Cheung R.T. Melatonin reduces nitric oxide level during ischemia but not blood-brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model. J. Pineal Res. 43 (2003) 110-118
23. Proud C.G. Protein phosphorylation in translational control. Curr. Top. Cell. Regul. 32 (1992) 243-369
24. Pullen N., and Thomas G. The modular phosphorylation and activation of p70S6K. FEBS Lett. 410 (1997) 78-82
25. Sun F.Y., Lin X., Mao L.Z., Ge W.H., Zhang L.M., Huang Y.N., and Gu J. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J. Pineal Res. 33 (2002) 48-56
26. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., and Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J. Pineal Res. 42 (2007) 28-42
27. Tan S., Sagara Y., Liu Y., Maher P., and Schubert D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141 (1998) 1423-1432
28. Vogt P.K. PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol. Med. 7 (2001) 482-484
29. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-x(L). Cell 87 (1996) 619-628